Epigenetic and microRNA-dependent control of cytochrome P450 expression: a gap between DNA and protein

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

Bibliography

• 1  Ingelman-Sundberg M, Sim SC, Gomez A et al.: Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol. Ther.116,496–526 (2007).▪ In this review, we present that a number of the drug-metabolizing members of the CYP superfamily are potentially under DNA methylation control due to the presence of high density CpG islands in their promoters.
  Medline CASGoogle Scholar
• 2  Rodríguez-Antona C, Ingelman-Sundberg M: Cytochrome P450 pharmacogenetics and cancer. Oncogene25,1679–1691 (2006).
  Medline CASGoogle Scholar
• 3  Ingelman-Sundberg M, Rodríguez-Antona C: Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapy. Philos. Trans. R Soc. Lond. B Biol. Sci.360,1563–1570 (2005).
  Medline CASGoogle Scholar
• 4  Estabrook RW: A passion for P450s (rememberances of the early history of research on cytochrome P450). Drug Metab. Dispos.31,1461–1473 (2003).
  Medline CASGoogle Scholar
• 5  Guengerich FP: Cytochrome P450s and other enzymes in drug metabolism and toxicity. AAPS J.8,E101–E111 (2006).
  Medline CASGoogle Scholar
• 6  Fukasawa T, Suzuki A, Otani K: Effects of genetic polymorphism of cytochrome P450 enzymes on the pharmacokinetics of benzodiazepines. J. Clin. Pharm. Ther.32,333–341 (2007).
  Medline CASGoogle Scholar
• 7  Ozdemir V, Kalow W, Tang BK et al.: Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method. Pharmacogenetics10,373–388 (2000).
  Medline CASGoogle Scholar
• 8  Reik W: Stability and flexibility of epigenetic gene regulation in mammalian development. Nature447,425–432 (2007).
  Medline CASGoogle Scholar
• 9  Klose RJ, Bird AP: Genomic DNA methylation: the mark and its mediators. Trends Biochem. Sci.31,89–97 (2006).
  Medline CASGoogle Scholar
• 10  Ballestar E, Esteller M: The impact of chromatin in human cancer: linking DNA methylation to gene silencing. Carcinogenesis23,1103–1109 (2002).
  Medline CASGoogle Scholar
• 11  Georgel PT: Role of chromatin/epigenetic modifications on DNA accessibility. Drug News Perspect.20,549–556 (2007).
  Medline CASGoogle Scholar
• 12  Galm O, Esteller M: Beyond genetics – the emerging role of epigenetic changes in hematopoietic malignancies. Int. J. Hematol.80,120–127 (2004).
  Medline CASGoogle Scholar
• 13  Baylin SB, Esteller M, Rountree MR et al.: Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum. Mol. Genet.10,687–692 (2001).
  Medline CASGoogle Scholar
• 14  Holliday R: Epigenetics: a historical overview. Epigenetics1,76–80 (2006).
  MedlineGoogle Scholar
• 15  Flanagan JM, Wild L: An epigenetic role for noncoding RNAs and intragenic DNA methylation. Genome Biol.8,307 (2007).
  MedlineGoogle Scholar
• 16  Matzke M, Matzke AJ, Kooter JM: RNA: guiding gene silencing. Science293,1080–1083 (2001).
  Medline CASGoogle Scholar
• 17  Pauler FM, Koerner MV, Barlow DP: Silencing by imprinted noncoding RNAs: is transcription the answer? Trends Genet.23,284–292 (2007).
  Medline CASGoogle Scholar
• 18  Costa FF: Non-coding RNAs: lost in translation? Gene386,1–10 (2007).
  Medline CASGoogle Scholar
• 19  Mattick JS, Makunin IV: Non-coding RNA. Hum. Mol. Genet.15(Spec. No. 1),R17–R29 (2006).
  Medline CASGoogle Scholar
• 20  Eddy SR: Non-coding RNA genes and the modern RNA world. Nat. Rev. Genet.2,919–929 (2001).
  Medline CASGoogle Scholar
• 21  Petronis A, Gottesman, II, Kan P et al.: Monozygotic twins exhibit numerous epigenetic differences: clues to twin discordance? Schizophr. Bull.29,169–178 (2003).
  MedlineGoogle Scholar
• 22  Fraga MF, Ballestar E, Paz MF et al.: Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl Acad. Sci. USA102,10604–10609 (2005).▪▪ Very important finding showing that in genetically similar monozygotic twins, phenotypic differences could occur through epigenetic means.
  Medline CASGoogle Scholar
• 23  Jaenisch R, Bird A: Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. (Suppl. 33),245–254 (2003).
  MedlineGoogle Scholar
• 24  Poulsen P, Esteller M, Vaag A et al.: The epigenetic basis of twin discordance in age-related diseases. Pediatr. Res.61,38R–42R (2007).
  MedlineGoogle Scholar
• 25  Esteller M: Epigenetics in cancer. N. Engl. J. Med.358,1148–1159 (2008).
  Medline CASGoogle Scholar
• 26  Bateson P, Barker D, Clutton-Brock T et al.: Developmental plasticity and human health. Nature430,419–421 (2004).
  Medline CASGoogle Scholar
• 27  Jiang YH, Bressler J, Beaudet AL: Epigenetics and human disease. Annu. Rev. Genomics Hum. Genet.5,479–510 (2004).
  Medline CASGoogle Scholar
• 28  Ptak C, Petronis A: Epigenetics and complex disease: from etiology to new therapeutics. Annu. Rev. Pharmacol. Toxicol.48,257–276 (2008).
  Medline CASGoogle Scholar
• 29  Heijmans BT, Tobi EW, Stein AD et al.: Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc. Natl Acad. Sci. USA105,17046–17049 (2008).
  Medline CASGoogle Scholar
• 30  Weaver IC, Cervoni N, Champagne FA et al.: Epigenetic programming by maternal behavior. Nat Neurosci.7,847–854 (2004).
  Medline CASGoogle Scholar
• 31  Jirtle RL, Skinner MK: Environmental epigenomics and disease susceptibility. Nat. Rev. Genet.8,253–262 (2007).
  Medline CASGoogle Scholar
• 32  Bestor TH: The DNA methyltransferases of mammals. Hum. Mol. Genet.9,2395–2402 (2000).
  Medline CASGoogle Scholar
• 33  Li E, Bestor TH, Jaenisch R: Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell69,915–926 (1992).
  Medline CASGoogle Scholar
• 34  Miranda TB, Jones PA: DNA methylation: the nuts and bolts of repression. J. Cell Physiol.213,384–390 (2007).
  Medline CASGoogle Scholar
• 35  Goll MG, Bestor TH: Eukaryotic cytosine methyltransferases. Annu. Rev. Biochem.74,481–514 (2005).
  Medline CASGoogle Scholar
• 36  Pradhan S, Esteve PO: Mammalian DNA (cytosine-5) methyltransferases and their expression. Clin. Immunol.109,6–16 (2003).
  Medline CASGoogle Scholar
• 37  Imai K, Yamamoto H: Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics. Carcinogenesis29,673–680 (2008).
  Medline CASGoogle Scholar
• 38  Kawasaki T, Nosho K, Ohnishi M et al.: IGFBP3 promoter methylation in colorectal cancer: relationship with microsatellite instability, CpG island methylator phenotype, and p53. Neoplasia9,1091–1098 (2007).
  Medline CASGoogle Scholar
• 39  Ogino S, Kawasaki T, Nosho K et al.: LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. Int. J. Cancer122,2767–2773 (2008).
  Medline CASGoogle Scholar
• 40  Doerfler W: De novo methylation, long-term promoter silencing, methylation patterns in the human genome, and consequences of foreign DNA insertion. Curr. Top. Microbiol. Immunol.301,125–175 (2006).
  Medline CASGoogle Scholar
• 41  Jass JR: Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology50,113–130 (2007).
  Medline CASGoogle Scholar
• 42  Raja P, Sanville BC, Buchmann RC et al.: Viral genome methylation as an epigenetic defense against geminiviruses. J. Virol.82,8997–9007 (2008).
  Medline CASGoogle Scholar
• 43  Hochstein N, Muiznieks I, Mangel L et al.: Epigenetic status of an adenovirus type 12 transgenome upon long-term cultivation in hamster cells. J. Virol.81,5349–5361 (2007).
  Medline CASGoogle Scholar
• 44  Sutter D, Westphal M, Doerfler W: Patterns of integration of viral DNA sequences in the genomes of adenovirus type 12-transformed hamster cells. Cell14,569–585 (1978).
  Medline CASGoogle Scholar
• 45  Rountree MR, Bachman KE, Herman JG et al.: DNA methylation, chromatin inheritance, and cancer. Oncogene20,3156–3165 (2001).
  Medline CASGoogle Scholar
• 46  Stirzaker C, Song JZ, Davidson B et al.: Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells. Cancer Res.64,3871–3877 (2004).
  Medline CASGoogle Scholar
• 47  Tate PH, Bird AP: Effects of DNA methylation on DNA-binding proteins and gene expression. Curr. Opin. Genet. Dev.3,226–231 (1993).
  Medline CASGoogle Scholar
• 48  Caiafa P, Zampieri M: DNA methylation and chromatin structure: the puzzling CpG islands. J. Cell Biochem.94,257–265 (2005).
  Medline CASGoogle Scholar
• 49  Keshet I, Lieman-Hurwitz J, Cedar H: DNA methylation affects the formation of active chromatin. Cell44,535–543 (1986).
  Medline CASGoogle Scholar
• 50  Padjen K, Ratnam S, Storb U: DNA methylation precedes chromatin modifications under the influence of the strain-specific modifier Ssm1. Mol. Cell Biol.25,4782–4791 (2005).
  Medline CASGoogle Scholar
• 51  Tokizane T, Shiina H, Igawa M et al.: Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. Clin. Cancer Res.11,5793–5801 (2005).▪ One of the most important papers in the field of P450 epigenetics showing the involvement of epigenetics, particularly DNA methylation, in the regulation of a CYP gene.
  Medline CASGoogle Scholar
• 52  Denissenko MF, Pao A, Tang M et al.: Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science274,430–432 (1996).
  Medline CASGoogle Scholar
• 53  Shimada T, Martin MV, Pruess-Schwartz D et al.: Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo(a)pyrene, 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons. Cancer Res.49,6304–6312 (1989).
  Medline CASGoogle Scholar
• 54  Shou M, Korzekwa KR, Crespi CL et al.: The role of 12 cDNA-expressed human, rodent, and rabbit cytochromes P450 in the metabolism of benzo[a]pyrene and benzo[a]pyrene trans-7,8-dihydrodiol. Mol. Carcinog.10,159–168 (1994).
  Medline CASGoogle Scholar
• 55  Whitlock JP Jr.: Induction of cytochrome P4501A1. Annu. Rev. Pharmacol. Toxicol.39,103–125 (1999).
  Medline CASGoogle Scholar
• 56  McLemore TL, Adelberg S, Liu MC et al.: Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J. Natl Cancer Inst.82,1333–1339 (1990).
  Medline CASGoogle Scholar
• 57  Pasquini R, Sforzolini GS, Cavaliere A et al.: Enzymatic activities of human lung tissue: relationship with smoking habits. Carcinogenesis9,1411–1416 (1988).
  Medline CASGoogle Scholar
• 58  Denison MS, Pandini A, Nagy SR et al.: Ligand binding and activation of the Ah receptor. Chem. Biol. Interact.141,3–24 (2002).
  Medline CASGoogle Scholar
• 59  Anttila S, Hakkola J, Tuominen P et al.: Methylation of cytochrome P4501A1 promoter in the lung is associated with tobacco smoking. Cancer Res.63,8623–8628 (2003).▪▪ Study showed that the environment, a very important factor in directing epigenetic changes, is instrumental in causing variation in drug response by affecting the expression of a CYP gene.
  Medline CASGoogle Scholar
• 60  Okino ST, Pookot D, Li LC et al.: Epigenetic inactivation of the dioxin-responsive cytochrome P4501A1 gene in human prostate cancer. Cancer Res.66,7420–7428 (2006).
  Medline CASGoogle Scholar
• 61  Murray GI, Melvin WT, Greenlee WF et al.: Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1. Annu. Rev. Pharmacol. Toxicol.41,297–316 (2001).
  Medline CASGoogle Scholar
• 62  Mimura J, Fujii-Kuriyama Y: Functional role of AhR in the expression of toxic effects by TCDD. Biochim. Biophys. Acta1619,263–268 (2003).
  Medline CASGoogle Scholar
• 63  Murray GI, Taylor MC, McFadyen MC et al.: Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res.57,3026–3031 (1997).
  Medline CASGoogle Scholar
• 64  McFadyen MC, Breeman S, Payne S et al.: Immunohistochemical localization of cytochrome P450 CYP1B1 in breast cancer with monoclonal antibodies specific for CYP1B1. J. Histochem. Cytochem.47,1457–1464 (1999).
  Medline CASGoogle Scholar
• 65  McFadyen MC, Cruickshank ME, Miller ID et al.: Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer. Br. J. Cancer85,242–246 (2001).
  Medline CASGoogle Scholar
• 66  Gunes A, Dahl ML: Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms. Pharmacogenomics9,625–637 (2008).
  CASGoogle Scholar
• 67  Quattrochi LC, Tukey RH: The human cytochrome CYP1A2 gene contains regulatory elements responsive to 3-methylcholanthrene. Mol. Pharmacol.36,66–71 (1989).
  Medline CASGoogle Scholar
• 68  Cross SH, Bird AP: CpG islands and genes. Curr. Opin. Genet. Dev.5,309–314 (1995).
  Medline CASGoogle Scholar
• 69  Jones PA, Takai D: The role of DNA methylation in mammalian epigenetics. Science293,1068–1070 (2001).
  Medline CASGoogle Scholar
• 70  Larsen F, Gundersen G, Lopez R et al.: CpG islands as gene markers in the human genome. Genomics13,1095–1107 (1992).
  Medline CASGoogle Scholar
• 71  Gardiner-Garden M, Frommer M: CpG islands in vertebrate genomes. J. Mol. Biol.196,261–282 (1987).
  Medline CASGoogle Scholar
• 72  Takai D, Jones PA: Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc. Natl Acad. Sci. USA99,3740–3745 (2002).
  Medline CASGoogle Scholar
• 73  Ghotbi R, Gomez A, Milani L et al.: Allele-specific expression and gene methylation in the control of CYP1A2 mRNA level in human livers. Pharmacogenomics J.9(3),208–217 (2009).
  Medline CASGoogle Scholar
• 74  Karlgren M, Gomez A, Stark K et al.: Tumor-specific expression of the novel cytochrome P450 enzyme, CYP2W1. Biochem. Biophys. Res. Commun.341,451–458 (2006).
  Medline CASGoogle Scholar
• 75  Gomez A, Karlgren M, Edler D et al.: Expression of CYP2W1 in colon tumors: regulation by gene methylation. Pharmacogenomics8,1315–1325 (2007).▪ CYP2W1 has been shown to be expressed in the developing embryo and is re-expressed in colon tumor through aberrant changes in DNA methylation.
  CASGoogle Scholar
• 76  Oneta CM, Lieber CS, Li J et al.: Dynamics of cytochrome P4502E1 activity in man: induction by ethanol and disappearance during withdrawal phase. J. Hepatol.36,47–52 (2002).
  Medline CASGoogle Scholar
• 77  Jones SM, Boobis AR, Moore GE et al.: Expression of CYP2E1 during human fetal development: methylation of the CYP2E1 gene in human fetal and adult liver samples. Biochem. Pharmacol.43,1876–1879 (1992).
  Medline CASGoogle Scholar
• 78  Vieira I, Pasanen M, Raunio H et al.: Expression of CYP2E1 in human lung and kidney during development and in full-term placenta: a differential methylation of the gene is involved in the regulation process. Pharmacol. Toxicol.83,183–187 (1998).
  Medline CASGoogle Scholar
• 79  Dannenberg LO, Edenberg HJ: Epigenetics of gene expression in human hepatoma cells: expression profiling the response to inhibition of DNA methylation and histone deacetylation. BMC Genomics7,181 (2006).
  MedlineGoogle Scholar
• 80  Nan X, Ng HH, Johnson CA et al.: Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature393,386–389 (1998).
  Medline CASGoogle Scholar
• 81  Staynov DZ: The controversial 30 nm chromatin fibre. Bioessays30,1003–1009 (2008).
  Medline CASGoogle Scholar
• 82  Luger K, Mäder AW, Richmond RK, Sargent DF, Richmond TJ: Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature389,251–260 (1997).
  Medline CASGoogle Scholar
• 83  Schones DE, Zhao K: Genome-wide approaches to studying chromatin modifications. Nat. Rev. Genet.9,179–191 (2008).
  Medline CASGoogle Scholar
• 84  Strahl BD, Allis CD: The language of covalent histone modifications. Nature403,41–45 (2000).
  Medline CASGoogle Scholar
• 85  Happel N, Stoldt S, Schmidt B et al.: M-phase-specific phosphorylation of histone H1.5 at threonine 10 by GSK-3. J. Mol. Biol.386(2),339–350 (2008).
  MedlineGoogle Scholar
• 86  Wu J, Huen MS, Lu LY et al.: Histone ubiquitination associates with BRCA1-dependent DNA damage response. Mol. Cell Biol.29,849–860 (2009).
  Medline CASGoogle Scholar
• 87  Nathan D, Ingvarsdottir K, Sterner DE et al.: Histone sumoylation is a negative regulator in Saccharomyces cerevisiae and shows dynamic interplay with positive-acting histone modifications. Genes Dev.20,966–976 (2006).
  Medline CASGoogle Scholar
• 88  Wang Y, Li M, Stadler S et al.: Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J. Cell Biol.184(2),205–213 (2009).
  Medline CASGoogle Scholar
• 89  Lafon-Hughes L, Di Tomaso MV, Mendez-Acuna L et al.: Chromatin-remodelling mechanisms in cancer. Mutat. Res.658,191–214 (2008).
  Medline CASGoogle Scholar
• 90  Cosgrove MS, Wolberger C: How does the histone code work? Biochem. Cell Biol.83,468–476 (2005).
  Medline CASGoogle Scholar
• 91  Jenuwein T, Allis CD: Translating the histone code. Science293,1074–1080 (2001).
  Medline CASGoogle Scholar
• 92  Schnekenburger M, Peng L, Puga A: HDAC1 bound to the CYP1A1 promoter blocks histone acetylation associated with Ah receptor-mediated trans-activation. Biochim. Biophys. Acta1769,569–578 (2007).
  Medline CASGoogle Scholar
• 93  Wei YD, Tepperman K, Huang MY et al.: Chromium inhibits transcription from polycyclic aromatic hydrocarbon-inducible promoters by blocking the release of histone deacetylase and preventing the binding of p300 to chromatin. J. Biol. Chem.279,4110–4119 (2004).
  Medline CASGoogle Scholar
• 94  Li Y, Cui Y, Hart SN, Klaassen CD, Zhong X: Dynamic patterns of histone methylation are associated with ontogenic expression of the Cyp3a genes during mouse liver maturation. Mol. Pharmacol.75(5),1171–1179 (2009).▪▪ The developmental switch in the expression of Cyp3 members in mice was shown in this study to be due to histone modification changes in a locus-specific manner while DNA methylation did not change.
  Medline CASGoogle Scholar
• 95  Ambros V: The functions of animal microRNAs. Nature431,350–355 (2004).
  Medline CASGoogle Scholar
• 96  Wienholds E, Plasterk RH: MicroRNA function in animal development. FEBS Lett.579,5911–5922 (2005).
  Medline CASGoogle Scholar
• 97  Tsuchiya Y, Nakajima M, Takagi S et al.: MicroRNA regulates the expression of human cytochrome P450 1B1. Cancer Res.66,9090–9098 (2006).
  Medline CASGoogle Scholar
• 98  Kalscheuer S, Zhang X, Zeng Y et al.: Differential expression of microRNAs in early-stage neoplastic transformation in the lungs of F344 rats chronically treated with the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis29,2394–2399 (2008).▪▪ The expression pattern of miRNAs in carcinogenesis could potentially lead to the expression of CYPs and even promote the carcinogenic process.
  Medline CASGoogle Scholar
• 99  Schembri F, Sridhar S, Perdomo C et al.: MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc. Natl Acad. Sci. USA106(7),2319–2324 (2009).
  Medline CASGoogle Scholar
• 100  Gonzalez FJ: CYP3A4 and pregnane X receptor humanized mice. J. Biochem. Mol. Toxicol.21,158–162 (2007).
  Medline CASGoogle Scholar
• 101  Takagi S, Nakajima M, Mohri T et al.: Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4. J. Biol. Chem.283,9674–9680 (2008).
  Medline CASGoogle Scholar
• 102  Mu YM, Yanase T, Nishi Y et al.: A nuclear receptor system constituted by RAR and RXR induces aromatase activity in MCF-7 human breast cancer cells. Mol. Cell Endocrinol.166,137–145 (2000).
  Medline CASGoogle Scholar
• 103  Youssef EM, Lotan D, Issa JP et al.: Hypermethylation of the retinoic acid receptor-β₍₂₎ gene in head and neck. Carcinogenesis Clin. Cancer Res.10,1733–1742 (2004).
  Medline CASGoogle Scholar
• 104  Bovenzi V, Momparler RL: Antineoplastic action of 5-aza-2´-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor β and estrogen receptor α genes in breast carcinoma cells. Cancer Chemother. Pharmacol.48,71–76 (2001).
  Medline CASGoogle Scholar
• 105  Tsuchiya Y, Nakajima M, Yokoi T: Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Lett.227,115–124 (2005).
  Medline CASGoogle Scholar
• 106  Westberry JM, Prewitt AK, Wilson ME: Epigenetic regulation of the estrogen receptor a promoter in the cerebral cortex following ischemia in male and female rats. Neuroscience152,982–989 (2008).
  Medline CASGoogle Scholar
• 201  Home Page of the Human Cytochrome P450 (CYP) Allele Nomenclature Committee. www.cypalleles.ki.se
  Google Scholar
• 202  microRNA.org: a resource for predicted microRNA targets and expression. www.microrna.org
  Google Scholar